Revolutionizing treatment for patients in need

Scroll To Discover
smiling Tarsus woman smiling Tarsus woman smiling Tarsus woman


We’re committed to delivering boundless therapeutic ingenuity

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of diseases with limited treatment options.


Novel therapies, beginning with the eye

For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is here.

News & Media

Here is the latest from Tarsus

03/05/2024 Tarsus to Participate at Upcoming Investor Conferences
03/05/2024 Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
03/01/2024 Tarsus Announces Pricing of $100.0 Million Public Offering

Contact Tarsus

Please reach out to us using the form below.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.